Results
3
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
3 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
ARGX | €582.60 | 7.9% | 28.9% | €35.2b | €578.70 | PS19.2x | E55.4% | n/a | Pharmaceuticals & Biotech | ||
UCB | €180.00 | 7.6% | 158.5% | €34.1b | €176.22 | PE142.3x | E35.9% | 0.8% | Pharmaceuticals & Biotech | ||
DIE | €204.80 | 3.2% | 30.4% | €10.9b | €262.60 | PE28.6x | E28.0% | 1.8% | Retail |